Literature DB >> 11391115

Cutaneous mucinoses: microscopic criteria for diagnosis.

F Rongioletti1, A Rebora.   

Abstract

The clinical aspects and the histologic features of cutaneous mucinoses have been reviewed and their classification updated. Cutaneous mucinoses are divided into distinctive (primary) cutaneous mucinoses in which the mucin deposit is the main histologic feature resulting in clinically distinctive lesions, and disorders associated with histologic mucin deposition as an additional finding (secondary mucinoses). The former are further divided into degenerative-inflammatory mucinoses, which may be either dermal or follicular, and into neoplastic-hamartomatous mucinoses. Histopathologic diagnosis is particularly difficult for dermal mucinoses and requires clinicopathologic correlation. Three histologic clues, namely the pattern of mucin distribution (diffuse or focal), the level of mucin deposit in the dermis and some additional findings may help diagnosis. Follicular mucinoses have the easiest pattern to recognize histologically, but the distinction between Pinkus' follicular mucinosis and follicular mucinosis with mycosis fungoides is very difficult.Lastly, neoplastic-hamartomatous cutaneous mucinoses include mucinous nevus, a benign hamartoma, and myxoma, which is a benign tumor to be differentiated from reactive cutaneous focal mucinosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391115     DOI: 10.1097/00000372-200106000-00022

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  23 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

3.  Cutaneous focal mucinosis of the scalp and adenocarcinoma of the lung: association or coincidence?

Authors:  Tiago Mestre; Fernando Assis-Pacheco; Jorge Cardoso
Journal:  J Bras Pneumol       Date:  2015 Mar-Apr       Impact factor: 2.624

Review 4.  [Scleromyxedema].

Authors:  M Neufeld; C Sunderkötter; R K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

5.  Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.

Authors:  Jessica S Kim; Victoria P Werth
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

6.  Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome.

Authors:  Allen P Miraflor; Melissa P Pulitzer; Patricia L Myskowski; Shamir Geller
Journal:  Am J Dermatopathol       Date:  2019-11       Impact factor: 1.533

Review 7.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

8.  Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.

Authors:  Julie Delyon; Maud Bézier; Michel Rybojad; Josette Brière; Pierre Validire; Martine Bagot; Anne Janin; Maxime Battistella
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

9.  Atypical presentation of cutaneous lupus mucinosis.

Authors:  Ryan Goerig; Chad Vogeler; Matthew Keller
Journal:  J Clin Aesthet Dermatol       Date:  2013-04

10.  Scleredema diabeticorum in a patient with type 2 diabetes mellitus.

Authors:  C Martín; L Requena; K Manrique; F D Manzarbeitia; A Rovira
Journal:  Case Rep Endocrinol       Date:  2011-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.